Bal Pharma FY26 net profit falls 13.4%, announces dividend

$BALPHARMA Bal Pharma reported a 13.4% decline in net profit to ₹675.12 lakh for FY26, while revenue increased 2.7% to ₹31,079.70 lakh. The board recommended a ₹1.20 per share dividend and approved a preferential issue of warrants and employee stock options.